[Certain problems of antiarrhythmia therapy in myocardial infarct].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000404:Ajmaline / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications*; D011342:Procainamide / Q000008:administration & dosage / Q000627:therapeutic use; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D011802:Quinidine / Q000008:administration & dosage / Q000627:therapeutic use
D000404:Ajmaline; D008012:Lidocaine; D011433:Propranolol; D011802:Quinidine; D011342:Procainamide
Nekotorye voprosy antiaritmicheskoĭ terapii pri infarkte miokarda